Channel Therapeutics Announces It Achieved Its Endpoints In Two Pre-Clinical In Vivo Models Of Its Nerve Block Formulations For Acute Pain
Channel Therapeutics Announces It Achieved Its Endpoints In Two Pre-Clinical In Vivo Models Of Its Nerve Block Formulations For Acute Pain
Channel Therapeutics宣佈其急性疼痛神經阻滯製劑在兩個臨床前體內模型中達到了預期目標。
Channel Therapeutics Announces It Achieved Its Endpoints In Two Pre-Clinical In Vivo Models Of Its Nerve Block Formulations For Acute Pain
Channel Therapeutics宣佈其急性疼痛神經阻滯製劑在兩個臨床前體內模型中達到了預期目標。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。